Skip to content
Wednesday 12 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,844.19
-0.17%
DAX
26,391.42
+0.26%
CAC 40
8,714.94
0.00%
STOXX 50
6,551.22
+0.24%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Wednesday 09 January 2019 3:03 pm  |  Updated:  Monday 03 June 2019 2:36 am

Star trader Neil Woodford’s fund reports healthy profits despite recent drop in assets

Veteran investor Neil Woodford’s fund Woodford Investments has reported operating profit of £41.7m and paid directors £36.5m in dividends in the 12 months to the end of March last year.

However, the accounts do not take into account recent outflows from the fund, and profits are likely to be impacted in the next set of full-year results.

Woodford sold around £1.4bn in the six months to November last year, according to reports, selling down positions in companies such as pharma business Astra Zeneca, brickmaker Forterra and travel website Hostelworld.

His flagship Equity Income Fund fell in value from £10.7bn in the summer of 2017 to £5.3bn in November.

The company's accounts for the previous year only cover a six-month period due to a change in legal structure. 

A spokesperson for Woodford said: “Profits are transferred into Woodford Capital to enable Woodford Investment to invest excess balance sheet cash of the limited company.

“The money is reinvested into the Woodford funds, such as Woodford Patient Capital Trust, used to make charitable donations, as well as providing an income for the directors.”

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Investing
  • Money

Related Topics

  • Company
  • Neil Woodford
  • People
  • Woodford Patient Capital Trust

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • Hargreaves Lansdown orders staff back to office

  • As it happened: Intel, Arm shares slide; Oil climbs higher

More from Morning Wire

  • Man Group shares surge as assets hit record $253bn

    Investing
    Man Group is the largest hedge fund in the UK.
  • Wind Point Partners Announces Final Close of Oversubscribed Fund XI at $3.2 Billion

    Business Wire
  • Stop burying us in swollen corporate reports, says audit watchdog boss

    Accountancy
    Richard Moriarty, FRC unveils new stewardship code reducing reporting burdens
  • Rolls-Royce share jump as profit beats expectations

    Industrials
    Rolls-Royce is a member of the FTSE 100. Credit - Getty.
  • Magic circle Freshfields ousts equity partners amid US push

    Legal
    Freshfields office building exterior with modern architecture, reflecting a business environment and corporate professiona...
  • ‘Ever-widening gap’: Wetherspoon boss Tim Martin urges Burnham to cut more pub taxes

    Hospitality
    Founder and Chairman of JD Wetherspoon, Tim Martin
  • Warning for John Healey as key fiscal target missed

    Economics
    Labour MP John Healey in a professional headshot, likely for news or political profile.
  • UK investors turn to bonds as equities valuations continue to stretch

    Markets
    Traders analyzing data on screens at London Stock Exchange, showcasing investment trends and market activity
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook